MedElevator
Войти в исследования Muscle & nerve · 2020
Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain-Barré syndrome.
Сравнительное исследованиеСтатьяResearch Support, N.I.H., IntramuralНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Beydoun Hind A, Beydoun May A, Hossain Sharmin, Zonderman Alan B, Eid Shaker M
Аннотация
BACKGROUND: We compared outcomes of therapeutic plasma exchange (TPE) vs intravenous immunoglobulin (IVIG) among hospitalized patients diagnosed with Guillain-Barré syndrome (GBS).
METHODS: In a retrospective cohort study of 6642 records (2637 TPE and 4005 IVIG) from the 2002-2014 Nationwide Inpatient Sample, treatment type was examined as predictor of length of stay, total charges, and in-hospital death, with regression modeling using risk adjustment and propensity scoring to control for confounders.
RESULTS: Compared with those receiving IVIG, patients who underwent TPE experienced prolonged hospitalization by approximately 7.5 days, greater hospitalization costs by approximately $46,000, and increased in-hospital death with an odds ratio of 2.78. Results did not change after controlling for confounders through risk adjustment, propensity score adjustment, or matching.
CONCLUSIONS: TPE may be associated with poorer healthcare utilization outcomes vs IVIG, although confounding by indication could not be ascertained.
METHODS: In a retrospective cohort study of 6642 records (2637 TPE and 4005 IVIG) from the 2002-2014 Nationwide Inpatient Sample, treatment type was examined as predictor of length of stay, total charges, and in-hospital death, with regression modeling using risk adjustment and propensity scoring to control for confounders.
RESULTS: Compared with those receiving IVIG, patients who underwent TPE experienced prolonged hospitalization by approximately 7.5 days, greater hospitalization costs by approximately $46,000, and increased in-hospital death with an odds ratio of 2.78. Results did not change after controlling for confounders through risk adjustment, propensity score adjustment, or matching.
CONCLUSIONS: TPE may be associated with poorer healthcare utilization outcomes vs IVIG, although confounding by indication could not be ascertained.
Предметные рубрики MeSH
AdolescentAdultAgedAged, 80 and overChildFemaleGuillain-Barre SyndromeHospital ChargesHospital MortalityHospitalizationHumansImmunoglobulins, IntravenousImmunologic FactorsLength of StayLinear ModelsLogistic ModelsMaleMiddle AgedPlasma ExchangePropensity ScoreRetrospective StudiesRisk AdjustmentUnited StatesYoung Adult